In the population-based Malmö Diet and Cancer Study–Cardiovascular cohort, plasma copeptin was associated with a combined end point (similar to the one we used in our study) composed of coronary heart disease, heart failure, and death in people with diabetes but not in non-diabetic individuals [18]. The gene discussed is AVP; the disease is heart failure.